Genzyme General raises $250 million:
This article was originally published in Clinica
Genzyme General has raised around $250 million in a private placement. The company, of Cambridge, Massachusetts, intends to expand its product portfolio but declined to comment specifically on its plans for the diagnostics and surgical businesses. Genzyme will also use the proceeds for general corporate purposes.